Skip to search formSkip to main contentSkip to account menu

taliglucerase alfa

Known as: L-glutamyl-l-phenylalanyl-(495(497)-l-histidine(r>h))human Glucosylceramidase (beta-glucocerebrosidase) Peptide with l-aspartyl-l-leucyl-l-leucyl-l-valyl-l-aspartyl-l-threonyl-l-methionine, Glycosylated Peptide 1-506, prGCD 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

Elelyso
GLUCOSYLCERAMIDASEanalogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Taliglucerase alfa in Gaucher disease: Description of a Brazilian experience.
2009
2009
Protalix BioTherapeutics to Present at the WORLD Lysosomal Disease Network
Protalix is a biopharmaceutical company. Its goal is to become a fully integrated biopharmaceutical company focused on the… 
Review
2009
Review
2009
FDA Pipeline preview, October 2009 (doxorubicin, trabectedin, carisbamate, alogliptin/pioglitazone, HPV vaccine, pralatrexate, romidepsin, hyaluronic acid, laromustine, clofarabine, prGCD, KNS-760704…
Recent FDA action (through October 2009) related to doxorubicin, trabectedin, carisbamate, alogliptin/pioglitazone, HPV vaccine… 
2008
2008
[Enzyme replacement therapy for Gaucher's Disease].
Rekombinant hergestellte Glucocerebrosidase (Imiglucerase, Cerezyme®) zur Therapie der lysosomalen Speicherkrankheit Morbus… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)